2018
DOI: 10.1590/2237-6089-2017-0077
|View full text |Cite
|
Sign up to set email alerts
|

Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria

Abstract: Introduction Assessing adherence in schizophrenia facilitates interventions that optimize outcomes. Adherence rating questionnaires are feasible and non-intrusive; however, no validated measure exists in sub-Saharan Africa. We aimed to assess the psychometric properties of the 10-item Medication Adherence Rating Scale (MARS). Methods This was a cross-sectional study of a cohort of patients with schizophrenia (n=230). A sociodemographic questionnaire, the Mini International Neuropsychiatric Interview (MINI), P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(28 citation statements)
references
References 22 publications
1
22
0
Order By: Relevance
“…13 The MARS covers three key aspects: behaviour towards medication adherence (items 1-4), attitude toward taking medication (items 5-8) and negative side effects (items 9 and 10). 14 Each question has a yes or no response. For questions 1-6 and 9-10, a "no" response is suggestive of compliance and given a score of 1.…”
Section: Measurementsmentioning
confidence: 99%
“…13 The MARS covers three key aspects: behaviour towards medication adherence (items 1-4), attitude toward taking medication (items 5-8) and negative side effects (items 9 and 10). 14 Each question has a yes or no response. For questions 1-6 and 9-10, a "no" response is suggestive of compliance and given a score of 1.…”
Section: Measurementsmentioning
confidence: 99%
“…It also consists of questions asking adherence and drug attitude, and the total score is the sum of these questions which is believed to measure adherence in a better quality [22,23]. Furthermore, we have preferred MARS over other screening tools because of its high reliability (Cronbach alpha � 0.76) and high internal consistency (α � 0.80) reported by previous study [24]. Patients who scored below 7 were considered as nonadherent to their antiepileptic medications [25].…”
Section: Outcome Variablementioning
confidence: 99%
“…Scores are treated as a continuous measure and a higher score indicates a greater compliance. The MARS demonstrated fair psychometric properties in a previous study ( Owie et al, 2018 ). Therefore, it was selected as one of the standards in this study.…”
Section: Research Instrumentsmentioning
confidence: 65%